152 related articles for article (PubMed ID: 36283925)
21. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
22. Desmoplastic and neurotropic melanoma.
Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.
Kunte C; Geimer T; Baumert J; Konz B; Volkenandt M; Flaig M; Ruzicka T; Berking C; Schmid-Wendtner MH
Melanoma Res; 2010 Aug; 20(4):330-7. PubMed ID: 20526218
[TBL] [Abstract][Full Text] [Related]
25. Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery.
MacArthur KM; Baumann BC; Sobanko JF; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; McMurray SL; Krausz A; Newman JG; Rajasekaran K; Cannady SB; Brody RM; Karakousis GC; Miura JT; Cohen JV; Amaravadi RK; Mitchell TC; Schuchter LM; Miller CJ
Cancer; 2021 Oct; 127(19):3591-3598. PubMed ID: 34292585
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node biopsy for melanoma: indications and rationale.
Phan GQ; Messina JL; Sondak VK; Zager JS
Cancer Control; 2009 Jul; 16(3):234-9. PubMed ID: 19556963
[TBL] [Abstract][Full Text] [Related]
27. Sentinel Lymph Node Biopsy in Cutaneous Melanoma, a Clinical Point of View.
Brănişteanu DE; Cozmin M; Porumb-Andrese E; Brănişteanu D; Toader MP; Iosep D; Sinigur D; Brănişteanu CI; Brănişteanu G; Porumb V; Pînzariu AC; Băilă SL; Nicolescu AC
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363546
[TBL] [Abstract][Full Text] [Related]
28. Desmoplastic melanoma.
Nicolson NG; Han D
J Surg Oncol; 2019 Jan; 119(2):208-215. PubMed ID: 30481377
[TBL] [Abstract][Full Text] [Related]
29. Use of Lymph Node Ultrasound Prior to Sentinel Lymph Node Biopsy in 384 Patients with Melanoma: A Cost-Effectiveness Analysis.
Olmedo D; Brotons-Seguí M; Del Toro C; González M; Requena C; Traves V; Pla A; Bolumar I; Moreno-Ramírez D; Nagore E
Actas Dermosifiliogr; 2017 Dec; 108(10):931-938. PubMed ID: 28801012
[TBL] [Abstract][Full Text] [Related]
30. Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the Literature.
Keung EZ; Krause KJ; Maxwell J; Morris CD; Crago AM; Houdek MT; Kane J; Lewis V; Callegaro D; Miller B; Lazar AJ; Gladdy R; Raut CP; Fabbri N; Al-Refaie W; Fairweather M; Wong SL; Roland CL
Ann Surg Oncol; 2023 Feb; 30(2):958-967. PubMed ID: 36307665
[TBL] [Abstract][Full Text] [Related]
31. Utility of Quantitative SPECT/CT Lymphoscintigraphy in Guiding Sentinel Lymph Node Biopsy in Head and Neck Melanoma.
Kwak JJ; Kesner AL; Gleisner A; Jensen A; Friedman C; McCarter MD; Koo PJ; Morgan RL; Kounalakis N
Ann Surg Oncol; 2020 May; 27(5):1432-1438. PubMed ID: 31773513
[TBL] [Abstract][Full Text] [Related]
32. A critical reappraisal of false negative sentinel lymph node biopsy in melanoma.
Manca G; Romanini A; Rubello D; Mazzarri S; Boni G; Chiacchio S; Tredici M; Duce V; Tardelli E; Volterrani D; Mariani G
Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):105-13. PubMed ID: 24835287
[TBL] [Abstract][Full Text] [Related]
33. Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional Collaboration.
Walker RJB; Look Hong NJ; Moncrieff M; van Akkooi ACJ; Jost E; Nessim C; van Houdt WJ; Stahlie EHA; Seo C; Quan ML; McKinnon JG; Wright FC; Mavros MN
Ann Surg Oncol; 2022 Oct; 29(11):7010-7017. PubMed ID: 35676603
[TBL] [Abstract][Full Text] [Related]
34. Transected thin melanoma: Implications for sentinel lymph node staging.
Herbert G; Karakousis GC; Bartlett EK; Zaheer S; Graham D; Czerniecki BJ; Fraker DL; Ariyan C; Coit DG; Brady MS
J Surg Oncol; 2018 Mar; 117(4):567-571. PubMed ID: 29194673
[TBL] [Abstract][Full Text] [Related]
35. Re-evaluation of Sentinel Lymph Node Biopsy for Melanoma.
Morrison S; Han D
Curr Treat Options Oncol; 2021 Feb; 22(3):22. PubMed ID: 33560505
[TBL] [Abstract][Full Text] [Related]
36. Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy.
Lens MB; Dawes M; Newton-Bishop JA; Goodacre T
Br J Surg; 2002 Oct; 89(10):1223-7. PubMed ID: 12296887
[TBL] [Abstract][Full Text] [Related]
37. Management of regional lymph nodes in the elderly melanoma patient: patient selection, accuracy and prognostic implications.
Grotz TE; Puig CA; Perkins S; Ballman K; Hieken TJ
Eur J Surg Oncol; 2015 Jan; 41(1):157-64. PubMed ID: 25468751
[TBL] [Abstract][Full Text] [Related]
38. Clinico-pathological features of patients with melanoma and positive sentinel lymph node biopsy: a single institution experience.
Homolak D; Šitum M; Čupić H
Acta Dermatovenerol Croat; 2015; 23(2):122-9. PubMed ID: 26228823
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node biopsy is a prognostic measure in pediatric melanoma.
Kim J; Sun Z; Gulack BC; Adam MA; Mosca PJ; Rice HE; Tracy ET
J Pediatr Surg; 2016 Jun; 51(6):986-90. PubMed ID: 27041229
[TBL] [Abstract][Full Text] [Related]
40. Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data.
Moroi Y
Int J Clin Oncol; 2009 Dec; 14(6):485-9. PubMed ID: 19967482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
